Clinical Trial Update: Clinical Benefit of Topoisomerase Downregulation [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating topoisomerase downregulation in ovarian cancer has completed and reports clinical benefit.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Ovarian Cancer | Phase 1 | Status: COMPLETED